Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

Here are 10 key points:

1. CONMED reported sales totaling $193.4 million, reflecting a 6.9 percent increase over the second quarter of 2015.

2. The company's domestic sells reflected 51 percent of total revenue, and increased 10.9 percent over the same period the year prior. The general surgery segment experienced growth, which offset orthopedics and visualization decreases.

3. International sales accounted for 49 percent of total revenue and increased 2.9 percent over the same period the year prior.

4. The company's net earnings hit $2.9 million for the second quarter.

5. Adjusted diluted net earnings per share totaled $0.47, compared to $0.43 in the same period the year prior.

Here are four key points:

1. Zimmer Biomet anticipates full-year adjusted earnings per share of $7.90 to $8. This estimate surpasses the company's previous forecast of $7.85 to $8 per share.

2. The company expects 2016 revenue to hit between $7.68 billion and $7.72 billion.

3. Zimmer Biomet experienced a net loss of $31.3 million for the quarter ending June 30.

4. The company's second quarter earnings hit $2.02 per share, an increase from $1.58 for the same period a year prior.

More articles on devices:
Orthofix's PHOENIX MIS Fixation System receives regulatory clearance in Japan: 5 things to know

Here are five things to know:

1. The PHOENIX MIS system is designed to enable the percutaneous placement of pedicle screws.

2. The system is intended to assist fusion in patients suffering from degenerative disc disease, spinal stenosis and trauma conditions in the middle and lower back.

3. The system design supports both percutaneous and mini-open surgical approaches.

4. According to GlobalData, by 2020 the spinal fusion market will be valued at $684 million in Japan.

5. Orthofix is a global medical device company focused on providing reconstructive and regenerative orthopedic and spine solutions.

More articles on devices:

3D printing prosthetics is changing the way those born with missing limbs or who have lost them due to accident, illness or war live their lives. The technology is in use today and brings life improving benefits to some of those least able to access traditional prosthetics. Furthermore, researchers are working on projects that will extend the opportunity to many others and also advance the field. These projects blend 3D printing, robotics and medicine and show how 3D printing can provide a unique solution to a real problem.

ST. PAUL, Minn.--(BUSINESS WIRE)--

St. Jude Medical, Inc. (STJ), a global medical device company, today reported sales and net earnings for the second quarter ended July 2, 2016.

Second quarter 2016 highlights:

Net sales of $1.562 billion increased 11 percent as reported, or 2 percent on a comparable constant currency basis.

International sales increased 10 percent as reported, or 7 percent on a comparable constant currency basis where a full portfolio of products is available.

Neuromodulation sales increased 19 percent as reported, or 20 percent on a constant currency basis driven by the most comprehensive product portfolio on the market.

Atrial fibrillation sales increased 13 percent as reported and on a constant currency basis driven by strong growth across the product portfolio.

Here are 10 things to know:

1. Stryker reported overall 16.8 percent net sales growth in the second quarter of 2016 to $2.8 billion. The company's three core business lines also reported net sales growth:

• Orthopedics — 4.6 percent
• MedSurg — 33.8 percent
• Neurotechnology and Spine — 9.3 percent

2. Net sales from the Sage Products and Physio-Control acquisitions contributed $240 million to the company's sales in the quarter.

3. Stryker had net earnings of $380 million in the second quarter, down 3.1 percent from the same period last year.

4. In the United States, Stryker reported net sales at $2 billion, a 19.2 percent increase over the same period last year.

Zimmer Biomet plans to acquire majority stake in MedTech, a France-based company focused on the ROSA Robotic System for brain and spine surgery.

Zimmer Biomet and Indo UK Institutes of Health announced plans for a multi-year collaboration.

MedTechreported a 73 percent increase in revenue for the full year 2016 over $7.2 million in 2015.

Medtronic received the first-ever FDA clearance for cement-augmented pedicle screws in the CD Horizon Fenestrated Screws.

The FDA cleared Medtronic's Prestige LP Cervical Disc for two-level applications.

Medtronic expanded its oblique lateral interbody fusion platform with its new Pivox Oblique Lateral Spinal System with Lateral Plate for OLIF25 and Divergence-L Anterior/Oblique Lumbar Fusion System for OLIF51.